Back to Authors

Suresh, Vinay

https://orcid.org/0000-0002-1401-9154

Mayo Clinic

University of Oxford

Citations 4

From Code to Clinic: A Phase-based Framework for AI Research in Healthcare (P1-15.004)
Panchawagh, Suhrud, Panchawagh, Suhrud , Suresh, Vinay , Sanker, Vivek

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215855 Get It

Current Trends and Future Prospects of Radiomics and Machine Learning (ML) Models in Spinal Tumors—A Narrative Review
Sanker, Vivek , Panchawgh, Suhrud, Kaur, Anmol, Suresh, Vinay , Mahesh, Dhanya, Ahmad, Eeman, Hariharan, Srinath, Pangal, Dhiraj J. , Cavgnaro, Maria Jose, Rusu, Mirabela , Ratliff, John K. , Suresh, Vinay , Ratliff, John , Kaur, Anmol , Hariharan, Srinath, Cavagnaro, María José , Desai, Atman

Journal of Imaging | March 19, 2026 | Volume: 12 | Issue: 3 | Pages: 138

10.3390/jimaging12030138 Get It

The intersection between radiomics, the computational analysis of imaging data, and machine learning (ML) may lead to new developments in the diagnosis, prognosis, and management of diseases. For spinal tumors specifically, applications of these fields appear promising. In this educational narrative review, we provide a summary of the current advancements in radiomics and artificial intelligence (AI), as well as applications of both fields in the diagnosis and management of spinal tumors. We also provide a suggested workflow of radiomics and machine learning analysis of spinal tumors for researchers, including a list and description of commonly used radiomic features. Future directions in the field of radiomics and machine learning applications to spinal tumors may involve validating already proposed algorithms with larger datasets, ensuring that all computational applications to patient care maintain high ethical standards, and continuing work in developing novel and highly accurate computational techniques to enhance patient outcomes.
A lightweight machine learning tool for Alzheimer's disease prediction
Suresh, Vinay , Nahar, Tulika , Sharma, Arkansh, Mohammed, Omer , Mishra, Devansh , Verma, Amogh , Mishra, Ayush, Malhotra, Hardeep Singh , Verma, Amogh , Suresh, Vinay , Sharma, Arkansh, Panchawagh, Suhrud , Mohammed, Omer, Muneer, Muneeb Ahmad , Mishra, Devansh, Sanker, Vivek , Garg, Ravindra Kumar , Mohammed, Omer

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | November 17, 2025 | Volume: 17 | Issue: 4 | Pages: No page available

10.1002/dad2.70187 Get It

Abstract INTRODUCTION Alzheimer's disease (AD) is a progressive neurodegenerative disorder that needs better predictive tools. Using the National Alzheimer's Coordinating Center Uniform Data Set, this study developed machine learning (ML) models and a practical clinical tool for AD prediction. METHODS Data from 52,537 individuals (22,371 with AD) and more than 200 variables were processed with MissForest imputation and genetic algorithm‐based selection. Multiple ML models were trained, and interpretability was performed using SHAP and permutation importance. A LightGBM model was refined through iterative backward feature elimination (IBFE) followed by manual refinement. RESULTS LightGBM performed best (receiver operating characteristic‐area under the curve [ROC‐AUC] 0.91, accuracy 82.0%). Key predictors included arthritis, age, body mass index, and heart rate. A 19‐feature model retained accuracy (81.2%) and ROC‐AUC (0.90). DISCUSSION This lightweight tool predicts AD using mostly routine variables. Limitations include its cross‐sectional nature, and would need external validation. An interactive web app and GitHub resource are available. Highlights Developed a lightweight ML based tool using 19 routinely available features. The lightweight model achieved an ROC-AUC of 0.90 for Alzheimer's disease prediction on NACC multicenter data. Genetic algorithm, IBFE, and manual refinement enabled optimal feature selection. Tool hosted on an open‐access platform for clinical and research use. SHAP analysis provided model interpretability and feature‐level insights.
Replicative significance index (RSI): A simulation-based metric for statistical inference and reproducibility
Suresh, Vinay , Bansal, Bhavik , Panchawagh, Suhrud

No container title available | September 9, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-7476592/v1 Get It

Abstract Background: Conventional null hypothesis significance testing, which relies heavily on p-values and confidence intervals, remains central to scientific research. However, both measures are subject to variability and may yield fragile or misleading conclusions. This has contributed to reproducibility concerns and the need for more informative inferential tools. Methods: We propose the Replicative Significance Index (RSI), a simulation-based metric that estimates the proportion of hypothetical replications that achieve statistical significance under identical design assumptions. The RSI directly models the stability of observed significance, in contrast to post hoc p-value interpretation or traditional power analysis. We further introduce a tail-augmented RSI (RSI*), which incorporates the depth of significant p-values through a tail-dominance adjustment. RSI and RSI* were implemented in R and demonstrated via conceptual examples, simulations under varying precision, and illustrative case scenarios of fragile significance and hidden robustness. Results: The simulations revealed that the RSI discriminates between superficially similar p-values that differ markedly in replicability and highlights cases where confidence intervals and p-values may overstate or understate robustness. RSI* further rewards distributions concentrated in the lower tail, distinguishing robustly reproducible findings from borderline significance. An R package and interactive Shiny web application are provided to facilitate implementation.